Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rik J Scheper

Showing results (81-90 of 177) with videos related to

Pageof 18
Sort By:
Clinical Immunology (Orlando, Fla.)|September 12, 2008
Invariant natural killer T cells and immunotherapy of cancerJohan W Molling, María Moreno, Hans J J van der Vliet, et al.
Experimental Dermatology|April 7, 2005
CD1d and CD1d-restricted iNKT-cells play a pivotal role in contact hypersensitivityEdward E S Nieuwenhuis, Silke Gillessen, Rik J Scheper, et al.
Journal of Tissue Engineering and Regenerative Medicine|April 16, 2020
Reconstructed human skin shows epidermal invagination towards integrated neopapillae indicating early hair follicle formation in vitroIrit Vahav, Lenie J van den Broek, Maria Thon, et al.
Immunotherapy|September 15, 2011
Glioblastoma-induced inhibition of Langerhans cell differentiation from CD34(+) precursors is mediated by IL-6 but unaffected by JAK2/STAT3 inhibitionHester van Cruijsen, Dinja Oosterhoff, Jelle J Lindenberg, et al.
Cancer Immunology Research|June 18, 2014
CD1d-restricted antigen presentation by Vγ9Vδ2-T cells requires trogocytosisFamke L Schneiders, Jan Prodöhl, Jurjen M Ruben, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2002
A panel of candidate tumor antigens in colorectal cancer revealed by the serological selection of a phage displayed cDNA expression libraryVeerle A Somers, Ricardo J Brandwijk, Ben Joosten, et al.
Cancer Biology & Therapy|March 9, 2005
High efficiency transduction of dendritic cells by adenoviral vectors targeted to DC-SIGNNikolay Korokhov, Tanja D de Gruijl, Wayne A Aldrich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2006
Dendritic cells require multidrug resistance protein 1 (ABCC1) transporter activity for differentiationRieneke van de Ven, Mariska C de Jong, Anneke W Reurs, et al.
Cancer Letters|August 8, 2008
Toll-like receptor agonists and invariant natural killer T-cells enhance antibody-dependent cell-mediated cytotoxicity (ADCC)María Moreno, Berber M Mol, Silvia von Mensdorff-Pouilly, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 2, 2002
Up-regulation of drug resistance-related vaults during dendritic cell developmentAnouk B Schroeijers, Anneke W Reurs, George L Scheffer, et al.
Pageof 18

Showing results (81-90 of 177) with videos related to

Sort By:
Pageof 18
Clinical Immunology (Orlando, Fla.)|September 12, 2008
Invariant natural killer T cells and immunotherapy of cancerJohan W Molling, María Moreno, Hans J J van der Vliet, et al.
Experimental Dermatology|April 7, 2005
CD1d and CD1d-restricted iNKT-cells play a pivotal role in contact hypersensitivityEdward E S Nieuwenhuis, Silke Gillessen, Rik J Scheper, et al.
Journal of Tissue Engineering and Regenerative Medicine|April 16, 2020
Reconstructed human skin shows epidermal invagination towards integrated neopapillae indicating early hair follicle formation in vitroIrit Vahav, Lenie J van den Broek, Maria Thon, et al.
Immunotherapy|September 15, 2011
Glioblastoma-induced inhibition of Langerhans cell differentiation from CD34(+) precursors is mediated by IL-6 but unaffected by JAK2/STAT3 inhibitionHester van Cruijsen, Dinja Oosterhoff, Jelle J Lindenberg, et al.
Cancer Immunology Research|June 18, 2014
CD1d-restricted antigen presentation by Vγ9Vδ2-T cells requires trogocytosisFamke L Schneiders, Jan Prodöhl, Jurjen M Ruben, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2002
A panel of candidate tumor antigens in colorectal cancer revealed by the serological selection of a phage displayed cDNA expression libraryVeerle A Somers, Ricardo J Brandwijk, Ben Joosten, et al.
Cancer Biology & Therapy|March 9, 2005
High efficiency transduction of dendritic cells by adenoviral vectors targeted to DC-SIGNNikolay Korokhov, Tanja D de Gruijl, Wayne A Aldrich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2006
Dendritic cells require multidrug resistance protein 1 (ABCC1) transporter activity for differentiationRieneke van de Ven, Mariska C de Jong, Anneke W Reurs, et al.
Cancer Letters|August 8, 2008
Toll-like receptor agonists and invariant natural killer T-cells enhance antibody-dependent cell-mediated cytotoxicity (ADCC)María Moreno, Berber M Mol, Silvia von Mensdorff-Pouilly, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 2, 2002
Up-regulation of drug resistance-related vaults during dendritic cell developmentAnouk B Schroeijers, Anneke W Reurs, George L Scheffer, et al.
Pageof 18